Biodegradable polymeric microparticles for drug delivery and vaccine formulation: The surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments

Biomaterials

Volumn 18, Issue 17, 1997, Pages 1153-1161

  Coombes, A G A ^a,d   Tasker, S ^a,e   Lindblad, M ^b   Holmgren, J ^b   Hoste, K ^c   Toncheva, V ^c   Schacht, E ^c   Davies, M C ^a   Illum, L ^a   Davis, S S ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c GHENT UNIVERSITY   (Belgium)

^d Quadrant Research Foundation   (United Kingdom)

^e St Pauls Cray ^*  (United Kingdom)

Author keywords

Dextran; Microparticles; Poly(ethylene glycol); Poly(lactide co glycolide); Surface modification

Indexed keywords

BIOASSAY; BIODEGRADATION; BIOMATERIALS; CONTROLLED DRUG DELIVERY; EMULSIFICATION; EVAPORATION; PARTICLE SIZE ANALYSIS; POLYETHYLENE GLYCOLS; STABILIZERS (AGENTS); SURFACE ACTIVE AGENTS; SURFACE TREATMENT; VACCINES;

IMMUNOSORBENT ASSAY;

COPOLYMERS;

DEXTRAN; MACROGOL; POLYGLACTIN; SODIUM CHLORIDE;

ARTICLE; CONJUGATE; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; EVAPORATION; HYDROPHILICITY; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPECTROSCOPY; SURFACE PROPERTY; TECHNIQUE; ZETA POTENTIAL;

BIOCOMPATIBLE MATERIALS; DEXTRANS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS; SOLVENTS; SPECTROMETRY, X-RAY EMISSION; SURFACE PROPERTIES; VACCINES; VOLATILIZATION;

EID: 0031238967     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(97)00051-3     Document Type: Article

References (42)

1. Allen, T. M. and Chonn, A., Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett., 1987, 223, 42-46.
2. Klibanov, A. L., Maruyama, K., Torchilin, V. P. and Huang, L., Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett., 1990, 268, 235-237.
3. Davis, S. S. and Illum, L., Polymeric microspheres as drug carriers. Biomaterials, 1987, 9, 111-115.
4. Stolnik, S., Dunn, S. E., Garnett, M. C. et al., Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm. Res., 1994, 11, 1800-1808.
5. Dunn, S., Coombes, A. G. A., Garnett, M. C., Davis, S. S., Davies, M. C. and Illum, L., In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers. J. Contr. Rel., 1997, 44, 65-76.
6. Dunn, S. E., Brindley, A., Davis, S. S., Davies, M. C. and Illum, L., Polystyrene-poly(ethylene glycol) (PS-PEG2000) particles as model systems for site-specific delivery. Part 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution. Pharm. Res., 1994, 11, 1016-1012.
7. Harper, G. R., Davies, M. C. D., Davis, S. S. et al., Steric stabilisation of microspheres with grafted polyethylene oxide reduces phagocytosis by rat Kupffer cells in vitro. Biomaterials, 1991, 12, 695-700.
8. Coombes, A. G. A., Scholes, P. D., Davies, M. C., Illum, L. and Davis, S. S., Resorbable polymeric microspheres for drug delivery-production and simultaneous surface modification using PEO-PPO surfactants. Biomaterials, 1994, 15, 673-680.
9. Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchlin, V. and Langer, R., Biodegradable long circulating polymeric nanospheres. Science, 1994, 263, 1600-1603.
10. Hagan, A. S., Coombes, A. G. A., Garnett, M. C. et al., Polylactide-poly(ethylene glycol) copolymers as drug delivery systems. 1. Characterisation of water dispersible micelle-forming systems. Langmuir, 1996, 12, 2153-2161.
11. Spanjer, H. H. and Scherphof, G., Targeting of lactosyl ceramide-containing liposomes to hepatocytes in vivo. Biochim. Biophys. Acta, 1983, 734, 40-47.
12. Litzinger, D. C. and Huang, L., Biodistribution and immunotargetability of ganglioside-stabilised dioleoylphosphatidylethanolamine liposomes. Biochim. Biophys. Acta, 1992, 1104, 179-187.
13. O'Hagan, D. T. (ed.), Novel Delivery Systems for Oral Vaccines. CRC Press, Boca Raton, FL, 1994, pp. 175-205.
14. Eldridge, J. H., Hammond, C. J., Meulbroek, J. A., Staas, J. K., Gilley, R. M. and Tice, T. R., Controlled vaccine release in the gut-associated lymphoid tissues. 1. Orally administered biodegradable microspheres target the Peyer's patches. J. Contr. Rel., 1990, 11, 205-214.
15. Hussain, N., Jani, P. U. and Florence, A. T., Intestinal uptake of lectin-conjugated microspheres. Proc. Int. Symp. Contr. Rel. Bioact. Mater., 1994, 21, 29-30.
16. Koosha, F., Muller, R. H., Davis, S. S. and Davies, M. C. D., The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process. J. Contr. Rel., 1989, 9, 149-157.
17. Hoste, K., Bruneel, D., De Marre, A., De Schrijver, F. and Schacht, E., Synthesis and characterisation of poly(oxyethylene) modified dextrans. Macromolec. Rapid Commun., 1994, 15, 697-704.
18. Florence, A. T. and Attwood, D., Physiochemical Principles of Pharmacy, 2nd edn. Macmillan, London, 1988, Chapter 7.
19. Dellacherie, E., Polymer-linked haemoglobin as a potential blood substitute. Clin. Mater., 1990, 6, 199-207.
20. Takakura, Y., Takagi, A., Hashida, M. and Sezaki, H., Disposition and tumor localisation of mitomycin C-dextran conjugates in mice. Pharm. Res., 1987, 4, 293-300.
21. Fessi, H., Devissaguet, J. P., Puisieux, F. and Thies, C., Demande de Brevet D'invention, No. 2608988, Republique Francaise, 1986.
22. Washington, C., Particle Size Analysis in Pharmaceutics and Other Industries: Theory and Practice. Ellis Horwood, Chichester, 1992, Chapter 7.
23. Davies, M. C. D., Short, R. D., Khan, M. A. et al., An XPS and SIMS analysis of biodegradable biomedical polyesters. Surface Interface Anal., 1989, 14, 115-120.
24. Johansson, G., Hedman, J., Berndtsson, A., Klasson, M. and Nilsson, R., Calibration of electron spectra. J. Electron. Spectrose., 1973, 2, 295-317.
25. Briggs, D. and Seah, M. P. (eds), Practical Surface Analysis, 2nd edn, Vol. 1. John Wiley, Chichester, 1990, Appendix 6.
26. Arshady, R., Microspheres and microcapsules, a survey of manufacturing techniques. Part III. Solvent evaporation. Polym. Eng. Sci., 1990, 30, 915-923.
27. Desai, N. P. and Hubbell, J. A., Solution technique to incorporate polyethylene oxide and other water soluble polymers into surfaces of polymeric biomaterials. Biomaterials, 1991, 12, 144-153.
28. Ruckenstein, E. and Byungup Chung, D., Surface modification by a two liquid deposition process of A-B block copolymers. J. Colloid Interface Sci., 1988, 123, 170-185.
29. Napper, D. H., Steric stabilisation. J. Colloid Interface Sci., 1977, 58, 390-407.
30. Tadros, Th. F. and Vincent, B., Influence of temperature and electrolytes on the adsorption of poly(ethylene oxide)-poly(propylene oxide) block copolymer on polystyrene latex and on the stability of the polymer coated particles. J. Phys. Chem., 1980, 84, 1575-1580.
31. Illum, L., Jacobsen, L. O., Muler, R. H., Mak, E. and Davis, S. S., Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials, 1987, 8, 113-117.
32. Lukowski, G., Muller, R. H., Muller, B. W. and Dittgen, M., Acrylic acid copolymer nanoparticles for drug delivery. Part 2. Characterisation of nanoparticles surface modified by adsorption of ethoxylated surfactants. Colloid Polym. Sci., 1993, 271, 100-105.
33. Beamson, G. and Briggs, D., High Resolution XPS of Organic Polymers - The Scienta ESCA 300 Database. John Wiley, Chichester, 1992.
34. Shard, A. G., Davies, M. C., Volland, C. and Kissel, T., Information on the monomer sequence of poly(lactic acid) and random copolymers of lactic acid and glycolic acid by examination of static secondary ion mass spectrometry ion intensities. Macromolecules, 1996, 29, 748-754.
35. Briggs, D. and Beamson, G., XPS studies of the oxygen Is and oxygen 2s levels in a wide range of functional polymers. Analyt, Chem., 1993, 65, 1517-1523.
36. Aubert, N., Mauzac, M. and Jozefowicz, M., Anticoagulant hydrogels derived from crosslinked dextran. Part 1. Synthesis, characterisation and antithrombic activity. Biomaterials, 1987, 8, 24-29.
37. Cremers, H. F. M., Kwon, G., Bae, Y. H. et al., Preparation and characterisation of albumin-heparin microspheres. Biomaterials, 1994, 15, 38-48.
38. Migonney, N., Fougnot, C. and Jozefowicz, M., Heparin-like tubings. Biomaterials, 1988, 9, 413-418.
39. Duncan, R., Kopacek, P., Rejmanova, P. and Lloyd, J. B., Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues. Biochim. Biophys. Acta, 1983, 755, 518-521.
40. Sedlik, C., Perraut, R., Bonnemains, B. and Leclerc, C., Antigens linked to synthetic microspheres induce immune responses in primates in the absence of adjuvant. Immunobiology, 1995, 195, 105-118.
41. Gombotz, W. R. and Pettit, D. K., Biodegradable polymers for protein and peptide drug delivery. Bioconjugate Chem., 1995, 6, 332-351.
42. Stok, W., van der Heijden, P. J. and Bianchi, A. T. J., Conversion of orally induced suppression of the mucosal immune response to ovalbumin into stimulation by conjugating ovalbumin to cholera toxin or its B subunit. Vaccine, 1994, 12, 521-526.